[ET Net News Agency, 10 June 2025] J.P. Morgan raised the target price for Innovent Bio
(01801) to HKD84 from HKD74 and maintained the "overweight" rating.
The research house said after IBI363's better-than-expected OS data at ASCO '25 boosted
Innovent's share price, it expects ongoing clinical catalysts to further drive
performance. (rc)
|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01801 INNOVENT BIO
Nominal 
80.700 -0.050 (-0.062%) Others
10/06/2025 14:42
{I-bank focus}J.P. Morgan raises Innovent Bio to HKD84
Next︰10/06/2025 09:01 {Block Trade}Trading session block trades at 9:00am
05/06/2025 14:59 {I-bank focus}BOCI raises Innovent Bio (01801) to HKD82
04/06/2025 09:31 {Hot Stocks}8 listed firms see price swing at 9:30am
03/06/2025 14:52 {I-bank focus}J.P. Morgan raises Innovent Bio to HKD74
02/06/2025 09:06 {Block Trade}Pre-opening block trades at 9:05am (1)
29/05/2025 09:06 {Block Trade}Pre-opening block trades at 9:05am
| Remark: | Real time quote last updated: 13/06/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |